187 related articles for article (PubMed ID: 37364046)
1. Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism.
Jones RB; Silva AD; Ankenbauer KE; Britain CM; Chakraborty A; Brown JA; Ballinger SW; Bellis SL
Glycobiology; 2023 Oct; 33(8):626-636. PubMed ID: 37364046
[TBL] [Abstract][Full Text] [Related]
2. Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics.
Ankenbauer KE; Rao TC; Mattheyses AL; Bellis SL
J Biol Chem; 2023 Oct; 299(10):105217. PubMed ID: 37660914
[TBL] [Abstract][Full Text] [Related]
3. Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.
Britain CM; Holdbrooks AT; Anderson JC; Willey CD; Bellis SL
J Ovarian Res; 2018 Feb; 11(1):12. PubMed ID: 29402301
[TBL] [Abstract][Full Text] [Related]
4. Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
Dorsett KA; Jones RB; Ankenbauer KE; Hjelmeland AB; Bellis SL
J Ovarian Res; 2019 Oct; 12(1):93. PubMed ID: 31610800
[TBL] [Abstract][Full Text] [Related]
5. Regulation of ST6GAL1 sialyltransferase expression in cancer cells.
Dorsett KA; Marciel MP; Hwang J; Ankenbauer KE; Bhalerao N; Bellis SL
Glycobiology; 2021 Jun; 31(5):530-539. PubMed ID: 33320246
[TBL] [Abstract][Full Text] [Related]
6. Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics.
Ankenbauer KE; Rao TC; Mattheyses AL; Bellis SL
bioRxiv; 2023 Jun; ():. PubMed ID: 37398202
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer.
Wichert B; Milde-Langosch K; Galatenko V; Schmalfeldt B; Oliveira-Ferrer L
Glycobiology; 2018 Nov; 28(11):898-903. PubMed ID: 30016515
[TBL] [Abstract][Full Text] [Related]
8. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
9. ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression.
Bhalerao N; Chakraborty A; Marciel MP; Hwang J; Britain CM; Silva AD; Eltoum IE; Jones RB; Alexander KL; Smythies LE; Smith PD; Crossman DK; Crowley MR; Shin B; Harrington LE; Yan Z; Bethea MM; Hunter CS; Klug CA; Buchsbaum DJ; Bellis SL
JCI Insight; 2023 Oct; 8(19):. PubMed ID: 37643018
[TBL] [Abstract][Full Text] [Related]
10. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
11. β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.
Lu J; Isaji T; Im S; Fukuda T; Hashii N; Takakura D; Kawasaki N; Gu J
J Biol Chem; 2014 Dec; 289(50):34627-41. PubMed ID: 25344606
[TBL] [Abstract][Full Text] [Related]
12. The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.
Jones RB; Dorsett KA; Hjelmeland AB; Bellis SL
J Biol Chem; 2018 Apr; 293(15):5659-5667. PubMed ID: 29475939
[TBL] [Abstract][Full Text] [Related]
13. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
[TBL] [Abstract][Full Text] [Related]
14. ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease.
Krick S; Helton ES; Easter M; Bollenbecker S; Denson R; Zaharias R; Cochran P; Vang S; Harris E; Wells JM; Barnes JW
Front Immunol; 2021; 12():693149. PubMed ID: 34290711
[TBL] [Abstract][Full Text] [Related]
15. The Inhibitory Role of α2,6-Sialylation in Adipogenesis.
Kaburagi T; Kizuka Y; Kitazume S; Taniguchi N
J Biol Chem; 2017 Feb; 292(6):2278-2286. PubMed ID: 28031460
[TBL] [Abstract][Full Text] [Related]
16. Extracellular sialyltransferase st6gal1 in breast tumor cell growth and invasiveness.
Hait NC; Maiti A; Wu R; Andersen VL; Hsu CC; Wu Y; Chapla DG; Takabe K; Rusiniak ME; Bshara W; Zhang J; Moremen KW; Lau JTY
Cancer Gene Ther; 2022 Nov; 29(11):1662-1675. PubMed ID: 35676533
[TBL] [Abstract][Full Text] [Related]
17. Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.
Hodgson K; Orozco-Moreno M; Goode EA; Fisher M; Garnham R; Beatson R; Turner H; Livermore K; Zhou Y; Wilson L; Visser EA; Pijnenborg JF; Eerden N; Moons SJ; Rossing E; Hysenaj G; Krishna R; Peng Z; Nangkana KP; Schmidt EN; Duxfield A; Dennis EP; Heer R; Lawson MA; Macauley M; Elliott DJ; Büll C; Scott E; Boltje TJ; Drake RR; Wang N; Munkley J
EBioMedicine; 2024 Jun; 104():105163. PubMed ID: 38772281
[TBL] [Abstract][Full Text] [Related]
18. α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth.
Gc S; Tuy K; Rickenbacker L; Jones R; Chakraborty A; Miller CR; Beierle EA; Hanumanthu VS; Tran AN; Mobley JA; Bellis SL; Hjelmeland AB
JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36345944
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of sialoglycopolypeptide for potentially blocking influenza virus infection using a rat alpha2,6-sialyltransferase expressed in BmNPV bacmid-injected silkworm larvae.
Ogata M; Nakajima M; Kato T; Obara T; Yagi H; Kato K; Usui T; Park EY
BMC Biotechnol; 2009 Jun; 9():54. PubMed ID: 19500344
[TBL] [Abstract][Full Text] [Related]
20. Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.
Lin N; Mascarenhas J; Sealover NR; George HJ; Brooks J; Kayser KJ; Gau B; Yasa I; Azadi P; Archer-Hartmann S
Biotechnol Prog; 2015; 31(2):334-46. PubMed ID: 25641927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
